 He is also exploring the roles of proteins and lectins that recognize glycans, as well as anti-glycan antibodies, in biological pathways and disease, including inflammation, autoimmunity, infectious diseases, and cancer.Cummings has over 300 peer-reviewed publications in the field, along with over 70 review articles, and dozens of book chapters.Cummings is an elected Fellow of the American Association for the Advancement of Science (2014), and a past President of the Society for Glycobiology (2001).